Welcome to our dedicated page for National Health Investors SEC filings (Ticker: NHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to locate rent coverage ratios or operator exposure across hundreds of pages in National Health Investors’ (NHI) disclosures? Healthcare REIT filings blend real-estate metrics with reimbursement regulations, making analysis time-consuming and error-prone.
Stock Titan solves that problem. Our AI-powered summaries transform the National Health Investors annual report 10-K simplified, the National Health Investors quarterly earnings report 10-Q filing, and every National Health Investors 8-K material events explained into concise insights you can act on. Need real-time alerts? The platform streams National Health Investors Form 4 insider transactions real-time, highlighting National Health Investors executive stock transactions Form 4 within minutes of hitting EDGAR.
Whether you are comparing dividend sustainability, monitoring lease maturities, or reviewing National Health Investors proxy statement executive compensation, our coverage spans all forms—10-K, 10-Q, 8-K, S-3, DEF 14A, and more. AI highlights segment NOI trends, interest-rate sensitivities, and debt covenants, then links directly to the source paragraph so you can verify numbers in context. Investors routinely use the service to (i) spot occupancy shifts before earnings, (ii) track operator concentration risk, and (iii) analyze repayment schedules—without paging through PDFs.
In short, if you’ve ever typed “National Health Investors SEC filings explained simply” or searched for “National Health Investors earnings report filing analysis,” this page delivers the answers, updated the moment each document posts.
National Health Investors, Inc. entered into new change in control severance agreements with five executive officers effective December 15, 2025, replacing agreements from February 2024. These contracts apply if an executive is terminated without “Cause” or resigns for “Good Reason” within two years after a change in control, or is terminated without “Cause” within 30 days before such an event.
If triggered, each executive receives a lump-sum cash payment equal to a multiple of the average of base salary and bonus for the last two calendar years (3.0 times for D. Eric Mendelsohn, 2.0 times for Kevin C. Pascoe and John L. Spaid, and 1.5 times for Kristin S. Gaines and David L. Travis), plus a lump-sum bonus at least equal to target, 18 months of COBRA health coverage, and accelerated vesting of time-based equity awards.
The agreements require a release of claims and add non-compete (for certain executives), non-solicitation for 12 months after severance is paid, and ongoing confidentiality obligations. Payments may be reduced to avoid excise tax under Section 4999 of the tax code if that yields higher after-tax proceeds for the executive.
National Health Investors Inc. director reports multiple stock option exercises and share withholding on December 9, 2025. The reporting person, acting as trustee, exercised several stock options, acquiring 25,000 shares of common stock at an exercise price of
National Health Investors, Inc. (NHI)11/20/2025, the director exercised a stock option to acquire 25,000 shares of common stock at an exercise price of $69.20 per share. On the same date, 22,135 shares of jointly held common stock were disposed of in a transaction coded "F," indicating shares were surrendered, typically to cover tax obligations, at a price of $78.16 per share. After these transactions, the director beneficially owned 31,555 shares of common stock jointly with a spouse and 500 shares in an IRA SEP, along with 10,000 stock options exercisable beginning 03/03/2025.
National Health Investors (NHI) announced upcoming Board changes. Robert G. Adams notified the company he will not stand for reelection at the 2026 annual meeting, and his term will end at that meeting.
Charlotte A. Swafford will retire from the Board effective May 27, 2026, immediately prior to the 2026 annual meeting. The company stated both decisions were not due to any disagreement regarding operations, policies, or practices.
National Health Investors (NHI) furnished its Supplemental Information for the quarter ended September 30, 2025 under Regulation FD via an 8‑K.
The materials are provided as Exhibit 99.1, dated November 6, 2025, and are also available on the company’s website. The filing lists this exhibit under Item 7.01 and includes a standard exhibit index in Item 9.01.
National Health Investors (NHI) filed its Q3 2025 10‑Q, showing higher quarterly profits and active portfolio repositioning. Total revenue was $89.8M vs $82.9M a year ago, driven by rental income of $62.2M, resident fees of $21.2M, and interest and other of $6.5M. Net income was $32.5M and diluted EPS was $0.69, up from $0.65. For the first nine months, revenue reached $269.8M and net income $103.0M.
Year to date, NHI closed $139.6M of acquisitions across senior housing communities, and subsequently added a $74.3M SHOP portfolio on
Cash from operations was $168.8M year to date, ending cash was $81.6M. Debt, net, was $1.11B, with activity including $346.2M of senior notes issued, substantial revolver and term loan repayments, and $134.9M of common equity issued. NHI declared a quarterly dividend of $0.92 per share. Shares outstanding were 47,638,502 as of
National Health Investors (NHI) insider filings show option exercises and open-market transactions by Travis David L. The filing reports two acquisitions of 11,666 and 11,334 shares of common stock on 09/23/2025 at a reported price of $69.20 each, and a disposition of 20,765 shares on 09/23/2025 at $80.06 per share. Following the reported non-derivative transactions, the filing lists beneficial ownership totals of 33,221, 44,555, and 23,790 shares in the respective reported lines. The Form 4 also discloses detailed option holdings and exercisable schedules, including multiple tranches with exercise prices ranging from $53.41 to $73.34 and expiration dates through 2030, and shows that several option exercises on 09/23/2025 resulted in zero remaining derivative securities for those specific grants. The report is signed by the reporting person on 09/24/2025.
FAQ
What is the current stock price of National Health Investors (NHI)?
What is the market cap of National Health Investors (NHI)?
